ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 359

$787K Total Retail Price of All Prescriptions

Rank: 12 out of 359

509 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,717 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 680 650 1 7
SIMVASTATIN 554 516 2 1
LISINOPRIL 470 423 3 3
AMLODIPINE BESYLATE 386 360 4 4
OMEPRAZOLE 362 333 5 6
FUROSEMIDE 354 354 6 5
LOSARTAN POTASSIUM 339 336 7 22
METFORMIN HCL 287 264 8 12
METOPROLOL TARTRATE 286 268 9 9
ATORVASTATIN CALCIUM 266 254 10 11
NAMENDA 240 240 11 30
HYDROCODONE-ACETAMINOPHEN 228 197 S3 12 2
PRAVASTATIN SODIUM 221 205 13 25
WARFARIN SODIUM 213 210 14 10
GLIMEPIRIDE 205 196 15 76
METOPROLOL SUCCINATE 204 191 16 8
DONEPEZIL HCL 203 203 17 23
GABAPENTIN 177 154 18 16
SERTRALINE HCL 174 170 19 27
CITALOPRAM HBR 163 159 20 37
TAMSULOSIN HCL 137 124 21 17
TORSEMIDE 132 131 22 120
POTASSIUM CHLORIDE 131 127 23 20
PANTOPRAZOLE SODIUM 129 120 24 28
CLOPIDOGREL 129 113 24 19
ALLOPURINOL 127 124 26 52
DIOVAN 123 123 27 50
HYDROCHLOROTHIAZIDE 121 107 28 15
CARVEDILOL 116 116 29 14
FAMOTIDINE 113 113 30 66
SPIRIVA 107 106 31 48
TRAMADOL HCL 107 106 31 24
ALENDRONATE SODIUM 106 104 33 32
ADVAIR DISKUS 105 97 34 39
PLAVIX 100 95 35 31
DIGOXIN 98 98 36 21
CRESTOR 91 89 37 26
AMLODIPINE BESYLATE-BENAZEPRIL 70 70 38 153
ATENOLOL 67 67 39 18
BUPROPION HCL SR 66 57 40 156
SYNTHROID 64 63 41 54
CLONIDINE HCL 64 62 41 110
ZETIA 63 62 43 96
ESCITALOPRAM OXALATE 62 56 44 70
SPIRONOLACTONE 59 59 45 62
TRIAMTERENE-HCTZ 57 49 46 164
PEN NEEDLE 57 53 46 86
GLYBURIDE 56 51 R 48 127
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 51 49 87
ISOSORBIDE MONONITRATE ER 53 45 50 51
LANTUS SOLOSTAR 53 53 50 122
DIOVAN HCT 52 52 52 205
SOTALOL 52 52 52 189
AMIODARONE HCL 51 51 54 118
HUMALOG 50 50 55 161
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.